A Decade of Success in Melanoma Immunotherapy and Targeted Therapy: What Every Radiologist Should Know
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Computer Assisted Tomography"
DOI: 10.1097/rct.0000000000001315
Abstract: Abstract Treatment strategies for malignant melanoma have rapidly evolved over the past decade. Because of its propensity to develop advanced stage and metastatic disease, melanoma has contributed to the majority of mortalities among patients with… read more here.
Keywords: melanoma; targeted therapy; decade; immunotherapy targeted ... See more keywords
Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e16656
Abstract: 511Background: Neoadjuvant immunotherapy with anti-programmed cell death protein-1 (PD-1) or anti-programmed cell death ligand-1 (PD-L1) and tyrosine kinase inhibitor (TKI) therapy is currently bei... read more here.
Keywords: immunotherapy; targeted therapies; effect neoadjuvant; neoadjuvant immunotherapy ... See more keywords
Distinct cytokines predict response to immunotherapy and targeted therapy in metastatic renal cell carcinoma (mRCC).
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.6_suppl.352
Abstract: 352Background: Previous studies have suggested a link between plasma cytokines and mRCC outcomes with systemic therapy. In a prospective study, we assessed whether plasma cytokines could separately... read more here.
Keywords: predict response; distinct cytokines; immunotherapy targeted; cytokines predict ... See more keywords
Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-020-09367-9
Abstract: Pancreatic cancer is one of the most aggressive gastrointestinal malignancies despite multimodality therapy. In the last several years, genomic studies have revealed that carcinogenesis is driven largely by key driver mutations that can be targeted… read more here.
Keywords: immunotherapy targeted; therapy; landmark series; pancreatic cancer ... See more keywords
The preliminary outcome of the combination of immunotherapy and targeted therapy after recurrence and metastasis for hereditary leiomyomatosis and renal cell cancer-a case report.
Sign Up to like & getrecommendations! Published in 2020 at "Translational andrology and urology"
DOI: 10.21037/tau.2019.12.37
Abstract: Hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated kidney cancer is a rare and exceptionally aggressive, with early metastasis and die at a young age. Most reported patients usually present with back pain and hematuria, and… read more here.
Keywords: combination immunotherapy; renal cell; combination; immunotherapy targeted ... See more keywords
Combined Immunotherapy and Targeted Therapies for Cancer Treatment: recent advances and future perspectives.
Sign Up to like & getrecommendations! Published in 2022 at "Current cancer drug targets"
DOI: 10.2174/1568009623666221020104603
Abstract: The previous year's worldview for cancer treatment has advanced from general to more precise therapeutics approaches. Chemotherapies were first distinguished as the most reliable and brief therapy with promising outcomes in cancer patients. However, patients… read more here.
Keywords: targeted therapies; therapy; immunotherapy targeted; cancer treatment ... See more keywords
Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2022.792676
Abstract: Recently, immunotherapy combined with targeted therapy has significantly prolonged the survival time and improved the quality of life of patients with hepatocellular carcinoma (HCC). However, HCC treatment remains challenging due to the high heterogeneity of… read more here.
Keywords: hcc; ferroptosis related; targeted therapy; immunotherapy targeted ... See more keywords
Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1103055
Abstract: Introduction The existence of many phase III randomized controlled trials (RCTs) of first-line treatment for unresectable hepatocellular carcinoma (HCC) puzzle doctors and patients in choosing the most effective treatment strategies. We aimed to assess the… read more here.
Keywords: cost effectiveness; analysis; first line; immunotherapy targeted ... See more keywords
Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Molecular Biosciences"
DOI: 10.3389/fmolb.2021.783915
Abstract: As a heterogeneous and aggressive disease, osteosarcoma (OS) faces great challenges to prognosis and individualized treatment. Hence, we explore the role of immune-related genes in predicting prognosis and responsiveness to immunotherapy and targeted therapies in… read more here.
Keywords: risk; prognosis; immunotherapy targeted; therapy ... See more keywords